Hemolytic uremic syndrome: An unusual complication of interferon-β treatment in a MS patient

Journal of Neurology

Volumn 260, Issue 7, 2013, Pages 1915-1916

  Nerrant, Elodie ^a   Charif, Mahmoud ^a   Ramay, Anne Sophie ^a   Perrochia, Hélène ^a   Patrier, Laure ^a   De Champfleur, Nicolas Menjot ^a   Renard, Dimitri ^b   Labauge, Pierre ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA1A INTERFERON; CORTICOSTEROID; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; UREA;

ADULT; ANASARCA; ANURIA; ASTHENIA; CASE REPORT; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; MULTIPLE SCLEROSIS; OLIGURIA; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PLASMAPHERESIS; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; ULTRAFILTRATION; UREA BLOOD LEVEL; WEIGHT GAIN;

ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 84880303602     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6961-8     Document Type: Letter

References (8)

1. Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol 69:292-302
2. Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361:1676-1687
3. Loirat C, Frémeaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6(1):60
4. Pisoni R, Ruggenenti P, Remuzzi G (2001) Drug-induced thrombotic microangiopathy: incidence, prevention and management. Drug Saf 24(7):491-501
5. Herrera WG, Balizet LB, Harberts SW, Brown ST (1999) Occurrence of a TTP-like syndrome in two women receiving beta interferon therapy for relapsing multiple sclerosis. Neurology 52(Suppl 2):A153
6. Auty A, Saleh A (2005) Nephrotic syndrome in a multiple sclerosis patient treated with interferon-β-1a. Can J Neurol Sci 32:366-368
7. Olea T, Diaz-Mancebo R, Picazo ML, Martinez-Ara J, Robles A, Selgas R (2012) Thrombotic microangiopathy associated with use of interferon-β. IJNRD 5:97-100
8. Broughton A, Cosyns JP, Jadoul M (2011) Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report. Clin Nephrol 76(5):396-400